期刊文献+

骨保护素对体外培养大鼠破骨细胞的影响 被引量:13

Effect of Osteoprotegerin on Rat Osteoclasts Formation and Activation in vitro
在线阅读 下载PDF
导出
摘要 【目的】探讨不同浓度骨保护素(osteoprotegerin,OPG)对破骨细胞(osteoclasts,OC)生成和活化的影响。【方法】通过成骨细胞(osteoblasts,OB)与脾细胞共培养的方法在体外诱导脾细胞转化为OC。采用形态学观察、抗酒石酸酸性磷酸酶(TRAP)染色计数、扫描电镜观察象牙片吸收陷窝方法检测OC的生成和活化。【结果】随着OPG浓度(5、10、25、50、75ng·ml-1)的增加,TRAP阳性OC数逐渐减少,各试验组与对照组比较差异均极显著(P<0.01);象牙片吸收陷窝的数目和面积也逐渐减少,OPG浓度为50ng·ml-1、75ng·ml-1时观测不到吸收陷窝。【结论】OPG通过抑制OC生成和活化,从而抑制OC的骨吸收,OPG浓度达50ng·ml-1以上可完全阻断OC的活化。 【Objective】To study the effect of different concentration of OPG on osteoclasts. 【Method】Osteoclasts were obtained by a co-culture system of osteoblasts with rat spleen cells, and supplemented with 5, 10, 25, 50 or 75 ng·ml-1 OPG, respectively. The formation and activation of osteoclasts were detected (or examined) by ways of morphologic observation, histochemical staining for tartrate-resistant acid phosphatase (TRAP) and detection of lacunar resorption through scanning electron micrograph. 【Results】Compared with the control group, the number of TRAP positive osteoclasts in experiment group decreased very significantly (P〈0.01). The number and area of lacunar resorption decreased with concentration increase of OPG. Lacunar resorption wasn’t detected in the group, which with more than 50 ng·ml-1 OPG. 【Conclusion】The resorption activity of osteoclasts is inhibited by inducing osteoclasts formation and activation via OPG.
出处 《中国农业科学》 CAS CSCD 北大核心 2008年第2期581-586,共6页 Scientia Agricultura Sinica
基金 国家自然科学基金资助项目(30440050,30571364) 江苏省高校自然科学研究指导性计划项目(05KJD230074) 江苏省高校“青蓝工程”优秀青年骨干教师资助项目(苏教师[2005]12) 江苏畜牧兽医职业技术学院院内课题(200503)
关键词 破骨细胞 骨保护素 抗酒石酸酸性磷酸酶 吸收陷窝 Osteoclast Osteoprotegerin Tartrate-resistant acid phosphatase Lacunar resorption
  • 相关文献

参考文献25

  • 1Kong Y Y, Penninger J M. Molecular control of bone remodeling and osteoporosis. Experimental Gerontology, 2000, 35: 947-956.
  • 2李雨民,李玉坤,张宇光,邱明才.成年大鼠破骨细胞体外培养及细胞凋亡的观察[J].中华骨科杂志,1999,19(9):565-567. 被引量:6
  • 3Lerner U H. Osteoclast formation and resorption. Matrix Biology, 2000, 19: 107-120.
  • 4Aldridge S E, Lennard T W J, Williams J R, Birch M A. Vascular endothelial growth factor receptors in osteoclast differentiation and function. Biochemical and Biophysical Research Communications, 2005. 335: 793-798.
  • 5刘加强,杨富生,卢开科.骨髓和脾脏中单核细胞形成破骨细胞能力的对比研究[J].牙体牙髓牙周病学杂志,2005,15(7):369-372. 被引量:4
  • 6Tsuda E, Goto M, Mochizuki S I, Yano K, Kobayashi F, Morinaga T, Higashio K. Isolation of a novel cytokine from human fibroblasts that specifically inhibits osteoclastogenesis. Biochemical and Biophysical Research Communication, 1997, 234(1): 137-142.
  • 7Simonet W S, Lacey D L, Dunstan C R, Kelley M, Chang M S, Ltithy R, Nguyen H Q, Wooden S, Bennett L, Boone T, Shimamoto G, DeRose M, Elliott R, Colombero A, Tan H L, Trail G, Sullivan J, Davy E, Bucay N, Gegg L R, Hughes T M, Hill D, Pattison W, Campbell P, Sander S, Van G, Tarpley J, Derby E Lee E Program A E, Boyle W J. Osteoprotegerin: A novel secreted protein involved in the regulation of bone density. Cell, 1997, 89: 309-319.
  • 8Mizuno A, Amizuka N, Irie K, Murakami A, Fujise N, Kanno T, Sato Y, Nakagawa N, Yasuda H, Mochizuki S H, Gomibuchi T, Yano K,Shima N, Washida N, Tsuda E, Morinaga T, Higashio K, Ozawa H.Severe osteoporosis in mice lacking osteoclastogenesis inhibitory factor/osteoprotegerin. Biochemical and Biophysical Research Communication, 1998, 247: 610-615.
  • 9Kong Y Y, Yoshida H, Sarosi I, Tan H L, Timms E, Capparelli C, Morony S, Oliveira-dos-Santos A J, Van G, Itie A, Khoo W, Wakeham A, Dunstan C R, Lacey D L, Mak T W, Boyle W J, Penninger J M. OPGL is a key regulator of osteoclastogenesis, lymphocyte development and lymph-node organogenesis. Nature, 1999, 397: 315-323.
  • 10Kong Y Y, Feige U, Sarosi I, Bolon B, Tafuri A, Morony S, Capparelli C, Li J, Elliott R, McCabe S, Wong T, Campagnuolo G, Moran E, Bogoch E R, Van G, Nguyen L T, Ohashi P S, Lacey D L, Fish E, Boyle W J, Penninger J M. Activated T cells regulate bone loss and joint destruction in adjuvant arthritis through osteoprotegerin ligand. Nature, 1999, 402: 304-309.

二级参考文献39

  • 1孙元明,杨福军,李雨民,卢飙,朱梅,邱明才.源于脾干细胞的破骨细胞诱导生成及培养[J].中国地方病学杂志,2003,22(2):101-103. 被引量:13
  • 2于明香,金慰芳,王洪复,关本博,林光义.破骨细胞体外培养与形态观察[J].上海医科大学学报,1996,23(1):52-54. 被引量:19
  • 3李雨民 张宇光.细胞凋亡的研究进展:1998的回顾[J].国外医学放射医学分册,1998,22:271-275.
  • 4李雨民,国外医学.放射医学核医学分册,1998年,22卷,271页
  • 5杨雁,安徽医科大学学报,1997年,32卷,300页
  • 6于明香,上海医科大学学报,1996年,23卷,52页
  • 7Yamane T, Kunisada T, Yamazaki H, et al. Sequential requirements for SCL/tal - 1, GATA -2, macrophage colony -stimulating factor, and osteoclast differentiation factor/osteoprotegerin ligand in osteoclast development[ J]. Exp Hematol,2000 ,28 :833 - 840
  • 8Martin TJ. Paracrine regulation of osteoclast formation and activity: milestones in discovery [ J ]. J Musculoskelet Neuronal Interact,2004,4 ( 3 ) :243 - 53
  • 9Thomas GP, Baker SUK, Eisman JA, et al. Changing RANKL/OPGmRNA expression in differentiating murine primary osteoblasts[ J]. J Endocrinology,2001,170:45124601
  • 10Mori SA. Osteoclast development in immobilized bone is suppressed by parathyroidectomy in mice[ J]. J Bone Miner Metab,2005,23(1):8-14

共引文献44

同被引文献222

引证文献13

二级引证文献108

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部